Clinical Trial Update: Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating liposomal doxorubicin for patients with recurrent or refractory mycosis fungoides (stages IIB, IVA, or IVB). The study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides

Drugs mentioned

• Doxil (liposomal doxorubicin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Lymphoma | Phase 2 | Status: COMPLETED